Please use this identifier to cite or link to this item:
http://repositorio.ufla.br/jspui/handle/1/41296| metadata.artigo.dc.title: | Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians |
| metadata.artigo.dc.creator: | Ghosh, Amerta Gupta, Ritesh Misra, Anoop |
| metadata.artigo.dc.subject: | COVID-19 Diabetes Telemedicine |
| metadata.artigo.dc.publisher: | Elsevier |
| metadata.artigo.dc.date.issued: | 2020 |
| metadata.artigo.dc.identifier.citation: | GHOSH, A.; GUPTA, R.; MISRA, A. Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, [S.l.], v. 14, n. 4, p. 273-276, July/Aug. 2020. |
| metadata.artigo.dc.description.abstract: | Background and aims In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario. Methods PubMed and Google Scholar search engines were searched using the key terms ‘telemedicine’, ‘diabetes’, ‘COVID-19 up to 31st March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India, were accessed. Results We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations. Conclusions Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required. |
| metadata.artigo.dc.identifier.uri: | https://www.sciencedirect.com/science/article/pii/S1871402120300606 http://repositorio.ufla.br/jspui/handle/1/41296 |
| metadata.artigo.dc.language: | en_US |
| Appears in Collections: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.